Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $296.47 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $104.63 | 5 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $53.94 | 3 | $0 (2022) |
| VBI Vaccines (Delaware) Inc. | $26.84 | 1 | $0 (2022) |
| Lilly USA, LLC | $26.31 | 2 | $0 (2022) |
| Esperion Therapeutics, Inc. | $20.62 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $19.11 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $18.29 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $13.63 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.10 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $203.49 | 11 | Novo Nordisk Inc ($56.67) |
| 2021 | $92.98 | 5 | Novo Nordisk Inc ($47.96) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2022 | VBI Vaccines (Delaware) Inc. | PreHevbrio (Drug) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: VACCINE | ||||||
| 08/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardio-renal | ||||||
| 05/10/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes | ||||||
| 05/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 04/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardio-renal | ||||||
| 04/08/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 03/11/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes | ||||||
| 03/02/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 02/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardio-renal | ||||||
| 01/07/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: VACCINES | ||||||
| 09/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 08/20/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/11/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Gastroenterology | ||||||
| 08/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 32 | 34 | $6,580 | $2,188 |
| 2021 | 2 | 36 | 40 | $5,520 | $1,951 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $5,500 | $1,832 | 33.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 11 | 12 | $1,080 | $355.72 | 32.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,000 | $1,118 | 37.3% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 12 | 14 | $1,260 | $416.64 | 33.1% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 12 | 14 | $1,260 | $416.64 | 33.1% |
About Nicole Reda
Nicole Reda is a Family healthcare provider based in Bomoseen, Vermont. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2020. The National Provider Identifier (NPI) number assigned to this provider is 1306452768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nicole Reda has received a total of $296.47 in payments from pharmaceutical and medical device companies, with $203.49 received in 2022. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($296.47).
As a Medicare-enrolled provider, Reda has provided services to 68 Medicare beneficiaries, totaling 74 services with total Medicare billing of $4,139. Data is available for 2 years (2021–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Bomoseen, VT
- Active Since 09/21/2020
- Last Updated 08/02/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306452768
Products in Payments
- Ozempic (Drug) $88.04
- Kerendia (Drug) $53.94
- PreHevbrio (Drug) $26.84
- TRULICITY (Drug) $26.31
- NEXLETOL (Drug) $20.62
- XARELTO (Drug) $19.11
- SHINGRIX (Biological) $18.29
- Rybelsus (Drug) $16.59
- INJECTAFER (Drug) $13.63
- XIFAXAN (Drug) $13.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.